↓ Skip to main content

Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches

Overview of attention for article published in Frontiers in Microbiology, August 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
2 news outlets
blogs
1 blog
twitter
31 X users

Citations

dimensions_citation
122 Dimensions

Readers on

mendeley
225 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches
Published in
Frontiers in Microbiology, August 2017
DOI 10.3389/fmicb.2017.01592
Pubmed ID
Authors

Viola C. Scoffone, Laurent R. Chiarelli, Gabriele Trespidi, Massimo Mentasti, Giovanna Riccardi, Silvia Buroni

Abstract

Burkholderia cenocepacia is an opportunistic pathogen particularly dangerous for cystic fibrosis (CF) patients. It can cause a severe decline in CF lung function possibly developing into a life-threatening systemic infection known as cepacia syndrome. Antibiotic resistance and presence of numerous virulence determinants in the genome make B. cenocepacia extremely difficult to treat. Better understanding of its resistance profiles and mechanisms is crucial to improve management of these infections. Here, we present the clinical distribution of B. cenocepacia described in the last 6 years and methods for identification and classification of epidemic strains. We also detail new antibiotics, clinical trials, and alternative approaches reported in the literature in the last 5 years to tackle B. cenocepacia resistance issue. All together these findings point out the urgent need of new and alternative therapies to improve CF patients' life expectancy.

X Demographics

X Demographics

The data shown below were collected from the profiles of 31 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 225 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 225 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 39 17%
Student > Ph. D. Student 37 16%
Student > Master 24 11%
Researcher 18 8%
Student > Doctoral Student 14 6%
Other 18 8%
Unknown 75 33%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 49 22%
Immunology and Microbiology 27 12%
Medicine and Dentistry 27 12%
Agricultural and Biological Sciences 17 8%
Chemistry 6 3%
Other 17 8%
Unknown 82 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 43. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 August 2022.
All research outputs
#1,007,539
of 26,262,977 outputs
Outputs from Frontiers in Microbiology
#542
of 30,147 outputs
Outputs of similar age
#19,778
of 331,141 outputs
Outputs of similar age from Frontiers in Microbiology
#7
of 527 outputs
Altmetric has tracked 26,262,977 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 30,147 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 331,141 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 527 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.